Choose a date range

From To

Choose one or more categories


Show only original CenterWatch stories


West Nile virus vaccine now in phase I clinical trials

Thursday, May 14, 2015 10:48 AM

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored phase I, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

More... »

Quest Diagnostics

Biogen names Matt Griffiths as chief information officer

Thursday, May 14, 2015 10:24 AM

Biogen has appointed Matt Griffiths as senior vice president and chief information officer. He will report to the company's executive vice president of technology and business solutions, Adriana Karaboutis. Griffiths was promoted to the chief information officer role from his position as vice president of pharmaceutical operations and corporate information technology, having joined Biogen from Dell earlier this year.

More... »

23andMe launches Lupus research study in collaboration with Pfizer

Thursday, May 14, 2015 10:19 AM

23andMe, a personal genetics company based in Mountain View, Calif., has launched the Lupus Research Study in collaboration with Pfizer. The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus. The effort also is in collaboration with the Lupus Research Institute and in concert with Lupus Awareness Month in May.

More... »

WHO draws lessons from Ebola to prepare roadmap for future epidemics

Wednesday, May 13, 2015 12:17 PM

The World Health Organization (WHO) has concluded a meeting on Ebola R&D to look at lessons learned from the outbreak and develop a roadmap for future epidemics.

More... »

Pfizer acquires minority interest in AM-Pharma; secures option to acquire company

Wednesday, May 13, 2015 12:15 PM

Pfizer has acquired a minority equity interest in AM-Pharma, a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP) for inflammatory diseases, and secured an exclusive option to acquire the remaining equity in the company.

More... »

Veeva to launch global registrations management solution

Wednesday, May 13, 2015 12:14 PM

California-based Veeva Systems will launch Veeva Vault Registrations, a comprehensive solution to manage product registration data worldwide, including registration status, variations and health authority interactions. The new offering will be part of Veeva’s regulatory information management (RIM) suite that also will include Vault Submissions and Vault SubmissionsArchive.

More... »

Juno Therapeutics acquires Stage Cell Therapeutics

Wednesday, May 13, 2015 12:11 PM

Juno Therapeutics, a Seattle, Wash.-based biopharmaceutical company focused on re-engaging the body's immune system to revolutionize the treatment of cancer, has acquired Stage Cell Therapeutics, a privately held biotechnology company based in Munich and Göttingen, Germany.

More... »

AstraZeneca inks personalized medicine partnerships with Abbott, Montreal Heart Institute

Wednesday, May 13, 2015 12:07 PM

AstraZeneca has formed collaborations with the Montreal Heart Institute (MHI) in Quebec, Canada, to search the genomes of up to 80,000 patients for genes associated with cardiovascular diseases and diabetes, their complications and treatment outcomes, and with Abbott to develop companion diagnostic tests to identify patients with severe asthma who are most likely to benefit from the investigational biological therapy tralokinumab.

More... »

Moderna launches venture company Elpidera for rare diseases

Wednesday, May 13, 2015 11:57 AM

Moderna Therapeutics, a Cambridge, Mass.-based developer of messenger RNA (mRNA) Therapeutics, has launched Elpidera, a new Moderna venture focused exclusively on the advancement of mRNA-based medicines for the treatment of rare diseases.

More... »

Eli Lilly, BioNTech form immune system research collaboration

Wednesday, May 13, 2015 11:56 AM

Eli Lilly and Biopharmaceutical New Technologies (BioNTech), a Germany-based immunotherapy company, have entered into a research collaboration to discover novel cancer immunotherapies. The companies will seek to use the power of the body’s own immune system to attack cancer cells and create possible new treatment options for cancer patients.

More... »


May 18

Research for All Act reaches Congress for second time seeking gender equality in basic research, clinical trials

MediciGlobal finds fewer trial dropouts among participants who actively pursue enrollment versus those recruited

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


Job satisfaction mixed as workload increases
Salaries not keeping pace with rise in work, responsibilities

Gamification moving from early science to patient use
Pharma looking to use games for early diagnosis, recruitment, adherence

Already a subscriber?
Log in to your digital subscription.

Purchase the May issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


PSI, INC Research, Chiltern best with sites
Strategic outsourcing prioritizing, improving site relationships

Regulatory compliance an increasing burden on sites
Increased staff time, materials, storage eroding site operating profit

Already a subscriber?
Log in to your digital subscription.

Purchase the April issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs